Both the dysregulation of the post-translational modification of the tau protein and the alteration of the degradative mechanisms of misfolded tau contribute to the pathological accumulation of tau aggregates that correlates with the neurodegeneration in AD [10,11]. This evidence concerns the gene MAPT and Alzheimer disease.